Immediate Management: Stop Azathioprine and Evaluate for Infection
Stop azathioprine immediately—this is the most likely cause of neutropenia in this clinical context, and continuing it risks life-threatening infection and bone marrow suppression 1.
Critical First Steps
1. Discontinue Azathioprine NOW
- Azathioprine commonly causes dose-dependent myelosuppression, particularly neutropenia 1
- The FDA label explicitly warns about severe blood disorders including agranulocytosis and leukopenia 1
- Gastrointestinal toxicity (diarrhea, nausea, vomiting) developing within the first weeks of therapy is a recognized hypersensitivity reaction that is reversible upon discontinuation 1
- This patient's presentation of diarrhea + neutropenia strongly suggests azathioprine toxicity
2. Assess Neutropenia Severity and Infection Risk
Obtain immediately:
- Absolute neutrophil count (ANC) to determine severity
- Blood cultures, urinalysis with culture
- Chest X-ray if any respiratory symptoms
- Stool studies (bacterial culture, C. difficile, ova and parasites)
- Consider CMV PCR and other opportunistic pathogens given immunosuppression
If ANC <500/μL or signs of infection (fever, sepsis): Hospitalize for empiric broad-spectrum antibiotics and G-CSF consideration
3. Continue Hydroxychloroquine
- Hydroxychloroquine should be continued unless contraindicated—it is standard of care for all SLE patients and reduces mortality 2, 3, 4
- Hydroxychloroquine does NOT typically cause neutropenia and provides disease control 2
Determine if This is Drug Toxicity vs. SLE Flare
Evidence Favoring Azathioprine Toxicity (Most Likely):
- Timing: GI symptoms + neutropenia together suggest drug hypersensitivity 1
- Pattern: Most episodes of severe granulocytopenia in SLE occur as drug toxicity-induced marrow hypoplasia 5
- Concomitant medications: Use of immunosuppressive drugs is associated with increased neutropenia risk 5
Evidence Favoring SLE Flare (Less Likely but Must Exclude):
- Check: Anti-dsDNA, complement levels (C3, C4), ESR, CRP
- Assess for other flare manifestations: new rash, arthritis, serositis, worsening proteinuria
- Important: Disease activity is typically LOWER during neutropenic episodes in SLE 5
- Lupus enteritis can present with chronic diarrhea but usually has imaging findings (bowel wall thickening, ascites) 6
Ongoing Management Algorithm
If Neutropenia Resolves After Stopping Azathioprine:
Switch maintenance immunosuppression (patient is on maintenance therapy for lupus nephritis):
First choice: Mycophenolate mofetil (MMF) 750-1000 mg twice daily 2
- Superior efficacy for lupus nephritis maintenance
- Continue for ≥36 months total immunosuppression duration 2
Alternative if MMF contraindicated: Calcineurin inhibitor (tacrolimus or voclosporin) 2
Consider adding belimumab if disease not well-controlled on monotherapy 7, 3
If Neutropenia Persists Despite Stopping Azathioprine:
- Check TPMT and NUDT15 genotyping (azathioprine metabolizing enzymes) 1
- Evaluate for SLE-related autoimmune neutropenia (anti-neutrophil antibodies)
- Bone marrow biopsy if unexplained persistent severe neutropenia
- Consider G-CSF if ANC remains critically low
Monitoring After Recovery
- Weekly CBC for first month, then twice monthly for 2-3 months after starting new immunosuppression 1
- Monitor renal function and proteinuria monthly
- Ensure hydroxychloroquine blood levels therapeutic (target 1000-1500 ng/mL) 2
Critical Pitfalls to Avoid
- Do NOT restart azathioprine—the reaction can recur within hours of re-challenge 1
- Do NOT assume this is purely SLE flare without stopping the offending drug first
- Do NOT delay switching to alternative immunosuppression—lupus nephritis requires continuous treatment to prevent progression 2
- Do NOT use co-trimoxazole prophylaxis with new immunosuppression if neutropenic—it can worsen leukopenia 1